J.P. Morgan raised its Medtronic MDT price target from $39 to $41 in a research report published today.
In the report, J.P. Morgan states, "Medtronic is scheduled to report 3Q results on Tuesday, February 22. Our forecast calls for revenues of $3.98B (+3.5% reported, 4.0% constant currency, and 2.0% organic) and EPS of $0.86 (+11.3%). Our forecast is largely in-line with consensus with one notable exception: on the tax line, where Medtronic should see a $30M ($0.03) catch-up benefit from the extension of the R&D tax credit during the quarter."
Shares of Medtronic were at $40.11 in Thursday after hours trading, down 0.39% from Thursday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in